NCT00211458View on ClinicalTrials.gov

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Macular Degeneration
Interventions
DRUG

Anecortave Acetate Sterile Suspension (15 mg)

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Manhattan Eye, Ear & Throat Hospital

OTHER